RUNX1同工型失衡促进21三体相关髓系白血病发生
研究聚焦21号染色体(Hsa21)获得如何促进白血病发生及唐氏综合征(DS)患儿白血病高发机制。通过Hsa21靶向CRISPR-Cas9筛选发现ML-DS细胞对RUNX1强依赖,RUNX1A同工型在ML-DS患者中表达升高;小鼠ML-DS模型和患者来源异种移植揭示过量RUNX1A与Gata1s突变协同,通过置换RUNX1C并联合MYC辅因子MAX诱导致癌程序;恢复RUNX1A:RUNX1C平衡或药物干扰MYC:MAX可逆转效应。
要点
- ML-DS细胞对RUNX1存在强而特异的依赖。
- RUNX1A同工型在ML-DS患者中表达升高。
- 过量RUNX1A与Gata1s协同,通过置换RUNX1C并联合MAX诱导致癌程序。
核心结论
- RUNX1同工型失衡伴RUNX1A偏倚是DS相关髓系白血病(ML-DS)的关键。
- 研究强调可变剪接在白血病发生中的重要性,即使在非整倍体背景下。
- 为ML-DS及其他Hsa21非整倍体或RUNX1同工型失衡白血病开发特异性靶向治疗铺平道路。
研究设计与样本
- 以Hsa21靶向CRISPR-Cas9筛选为起点,结合小鼠ML-DS模型和患者来源异种移植(PDX)进行机制研究,并在PDX中体外和体内验证。
主要发现
- Hsa21靶向CRISPR-Cas9筛选发现ML-DS细胞对RUNX1强而特异的依赖。
- RUNX1A同工型在ML-DS患者中表达升高。
- 小鼠ML-DS模型和PDX显示过量RUNX1A与Gata1s突变协同,通过置换RUNX1C并联合MAX诱导致癌程序。
- 在PDX中体外和体内恢复RUNX1A:RUNX1C平衡可逆转上述效应。
- 使用MYCi361药物干扰MYC:MAX二聚化产生强抗白血病效应。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Gain of chromosome 21 (Hsa21) is among the most frequent aneuploidies in leukemia. However, it remains unclear how partial or complete amplifications of Hsa21 promote leukemogenesis and why children with Down syndrome (DS) (ie, trisomy 21) are particularly at risk of leukemia development. Here, we propose that RUNX1 isoform disequilibrium with RUNX1A bias is key to DS-associated myeloid leukemia (ML-DS). Starting with Hsa21-focused CRISPR-CRISPR-associated protein 9 screens, we uncovered a strong and specific RUNX1 dependency in ML-DS cells. Expression of the RUNX1A isoform is elevated in patients with ML-DS, and mechanistic studies using murine ML-DS models and patient-derived xenografts revealed that excess RUNX1A synergizes with the pathognomonic Gata1s mutation during leukemogenesis by displacing RUNX1C from its endogenous binding sites and inducing oncogenic programs in complex with the MYC cofactor MAX. These effects were reversed by restoring the RUNX1A:RUNX1C equilibrium in patient-derived xenografts in vitro and in vivo. Moreover, pharmacological interference with MYC:MAX dimerization using MYCi361 exerted strong antileukemic effects. Thus, our study highlights the importance of alternative splicing in leukemogenesis, even on a background of aneuploidy, and paves the way for the development of specific and targeted therapies for ML-DS, as well as for other leukemias with Hsa21 aneuploidy or RUNX1 isoform disequilibrium.
引用
- Gialesaki S, Bräuer-Hartmann D, Issa H, et al. RUNX1 isoform disequilibrium promotes the development of trisomy 21-associated myeloid leukemia. Blood. 2023. PMID: 36493345. doi:10.1182/blood.2022017619
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。